[Analysis of costs and profits of ambulatory care of Marfan patients after initiation of a novel German legal directive (116 b SGB V)].

Standard

[Analysis of costs and profits of ambulatory care of Marfan patients after initiation of a novel German legal directive (116 b SGB V)]. / Manow, Marie-Luise; Paulsen, Nesrin; Rybczynski, Meike; Mir, Thomas; Bernhardt, Alexander; Treede, Hendrik; Ohm, Gunda; Fuisting, Bettina; Rehder, Uwe; Meier, Florian; Vogler, Marina; Meinertz, Thomas; Overlack, Karin; Von Kodolitsch, Yskert.

in: MED KLIN-INTENSIVMED, Jahrgang 105, Nr. 8, 8, 2010, S. 529-537.

Publikationen: SCORING: Beitrag in Fachzeitschrift/ZeitungSCORING: ZeitschriftenaufsatzForschungBegutachtung

Harvard

Manow, M-L, Paulsen, N, Rybczynski, M, Mir, T, Bernhardt, A, Treede, H, Ohm, G, Fuisting, B, Rehder, U, Meier, F, Vogler, M, Meinertz, T, Overlack, K & Von Kodolitsch, Y 2010, '[Analysis of costs and profits of ambulatory care of Marfan patients after initiation of a novel German legal directive (116 b SGB V)].', MED KLIN-INTENSIVMED, Jg. 105, Nr. 8, 8, S. 529-537. <http://www.ncbi.nlm.nih.gov/pubmed/20824410?dopt=Citation>

APA

Manow, M-L., Paulsen, N., Rybczynski, M., Mir, T., Bernhardt, A., Treede, H., Ohm, G., Fuisting, B., Rehder, U., Meier, F., Vogler, M., Meinertz, T., Overlack, K., & Von Kodolitsch, Y. (2010). [Analysis of costs and profits of ambulatory care of Marfan patients after initiation of a novel German legal directive (116 b SGB V)]. MED KLIN-INTENSIVMED, 105(8), 529-537. [8]. http://www.ncbi.nlm.nih.gov/pubmed/20824410?dopt=Citation

Vancouver

Bibtex

@article{8ef6028008aa465d8e558a35bbbd488b,
title = "[Analysis of costs and profits of ambulatory care of Marfan patients after initiation of a novel German legal directive (116 b SGB V)].",
abstract = "The Marfan syndrome is a typical rare disease with multiorgan involvement and the need for specialized interdisciplinary medical care. A novel German legal directive according to section sign 116 b of the Social Statutes Book V (116 b SGB V) improves options for reimbursement and thus encourages specialized hospitals to provide ambulatory care for rare diseases such as Marfan syndrome. The authors provide the first economic analysis of section sign 116 b in a German Marfan center.",
author = "Marie-Luise Manow and Nesrin Paulsen and Meike Rybczynski and Thomas Mir and Alexander Bernhardt and Hendrik Treede and Gunda Ohm and Bettina Fuisting and Uwe Rehder and Florian Meier and Marina Vogler and Thomas Meinertz and Karin Overlack and {Von Kodolitsch}, Yskert",
year = "2010",
language = "Deutsch",
volume = "105",
pages = "529--537",
journal = "MED KLIN-INTENSIVMED",
issn = "2193-6218",
publisher = "Springer Medizin",
number = "8",

}

RIS

TY - JOUR

T1 - [Analysis of costs and profits of ambulatory care of Marfan patients after initiation of a novel German legal directive (116 b SGB V)].

AU - Manow, Marie-Luise

AU - Paulsen, Nesrin

AU - Rybczynski, Meike

AU - Mir, Thomas

AU - Bernhardt, Alexander

AU - Treede, Hendrik

AU - Ohm, Gunda

AU - Fuisting, Bettina

AU - Rehder, Uwe

AU - Meier, Florian

AU - Vogler, Marina

AU - Meinertz, Thomas

AU - Overlack, Karin

AU - Von Kodolitsch, Yskert

PY - 2010

Y1 - 2010

N2 - The Marfan syndrome is a typical rare disease with multiorgan involvement and the need for specialized interdisciplinary medical care. A novel German legal directive according to section sign 116 b of the Social Statutes Book V (116 b SGB V) improves options for reimbursement and thus encourages specialized hospitals to provide ambulatory care for rare diseases such as Marfan syndrome. The authors provide the first economic analysis of section sign 116 b in a German Marfan center.

AB - The Marfan syndrome is a typical rare disease with multiorgan involvement and the need for specialized interdisciplinary medical care. A novel German legal directive according to section sign 116 b of the Social Statutes Book V (116 b SGB V) improves options for reimbursement and thus encourages specialized hospitals to provide ambulatory care for rare diseases such as Marfan syndrome. The authors provide the first economic analysis of section sign 116 b in a German Marfan center.

M3 - SCORING: Zeitschriftenaufsatz

VL - 105

SP - 529

EP - 537

JO - MED KLIN-INTENSIVMED

JF - MED KLIN-INTENSIVMED

SN - 2193-6218

IS - 8

M1 - 8

ER -